ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
Overview | Financials
Company Name | ANI Pharmaceuticals, Inc. |
Symbol | ANIP |
Currency | USD |
Price | 58.19 |
Market Cap | 1,223,741,519 |
Dividend Yield | 0% |
52-week-range | 48.2 - 70.81 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nikhil Lalwani |
Website | https://www.anipharmaceuticals.com |
An error occurred while fetching data.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD